Key Takeaways
- • Over 20% of healthcare companies that filed for bankruptcy in 2023 were owned by private equity firms, according to a report from the Private Equity Stakeholder Project released in April 2024, with 2023 marking a five-year peak in healthcare bankruptcies overall.
- • Private equity-backed healthcare companies carry among the highest debt loads in the industry, making them acutely vulnerable to market pressures; debt pricing is identified as the primary driver of the bankruptcy surge by PESP healthcare director Eileen O'Grady.
- • Private equity firms employ "aggressive debt-funded growth strategies" including dividend recapitalizations—using debt to finance initial investments and distribute returns to investors—strategies that leave portfolio companies structurally vulnerable to interest rate fluctuations and economic headwinds.
- • Healthcare bankruptcies trigger cascading systemic disruptions including facility closures, workforce layoffs, and care access disruptions that stress broader healthcare infrastructure when patients must travel to neighboring facilities during service interruptions.
- • Another wave of private equity-backed healthcare bankruptcies is forecast for 2024, as nearly all U.S. healthcare companies currently classified as high-risk for default are backed by private equity.
Summary
Private equity ownership is now substantially correlated with healthcare sector bankruptcy risk. The Private Equity Stakeholder Project's April 2024 report documents that over 20% of healthcare companies filing for bankruptcy in 2023 were owned by private equity firms, a striking concentration given that PE-backed firms represent a subset of the overall healthcare industry. This finding emerged as 2023 registered a five-year peak in total healthcare bankruptcies, according to restructuring firm Gibbins Advisors.
The proximate cause, according to PESP analysis, centers on debt structure and financing mechanics. Private equity acquirers typically deploy debt-financed acquisition strategies and use dividend recapitalizations—transactions where debt finances both investor payouts and operational investments—leaving portfolio companies with elevated leverage ratios. PESP healthcare director Eileen O'Grady emphasized in interviews that "the price of debt is the number one factor in this trend," positioning interest rate sensitivity as the critical vulnerability. This contrasts with alternative explanations cited in broader healthcare research, which attribute bankruptcies to rising labor costs, deteriorating payer-provider relationships, and general macroeconomic pressures. However, PESP's analysis suggests that while these factors affect the broader market, the concentration of bankruptcies among PE-backed firms indicates that debt load amplifies vulnerability disproportionately.
The operational and systemic consequences extend beyond individual company failures. Bankruptcies trigger facility closures, workforce reductions, and service disruptions that create secondary effects on healthcare infrastructure. When facilities shut, patient volumes redistribute to neighboring providers, creating capacity strain and extended travel requirements. These dynamics stress regional healthcare systems and may ultimately reduce access to care in underserved markets.
Looking forward, PESP projects escalating risk. The organization reports that almost all U.S. healthcare companies currently rated as high-default-risk are backed by private equity, positioning 2024 for another wave of PE-linked bankruptcies. This forecast assumes stable or rising interest rates and suggests that portfolio company refinancing and debt maturity events will continue testing the viability of highly leveraged PE healthcare acquisitions. For institutional investors and fund managers tracking healthcare sector dynamics, the correlation between PE ownership and bankruptcy risk represents a material consideration in valuations, debt securities, and systemic risk assessments across healthcare provider and services segments.
The proximate cause, according to PESP analysis, centers on debt structure and financing mechanics. Private equity acquirers typically deploy debt-financed acquisition strategies and use dividend recapitalizations—transactions where debt finances both investor payouts and operational investments—leaving portfolio companies with elevated leverage ratios. PESP healthcare director Eileen O'Grady emphasized in interviews that "the price of debt is the number one factor in this trend," positioning interest rate sensitivity as the critical vulnerability. This contrasts with alternative explanations cited in broader healthcare research, which attribute bankruptcies to rising labor costs, deteriorating payer-provider relationships, and general macroeconomic pressures. However, PESP's analysis suggests that while these factors affect the broader market, the concentration of bankruptcies among PE-backed firms indicates that debt load amplifies vulnerability disproportionately.
The operational and systemic consequences extend beyond individual company failures. Bankruptcies trigger facility closures, workforce reductions, and service disruptions that create secondary effects on healthcare infrastructure. When facilities shut, patient volumes redistribute to neighboring providers, creating capacity strain and extended travel requirements. These dynamics stress regional healthcare systems and may ultimately reduce access to care in underserved markets.
Looking forward, PESP projects escalating risk. The organization reports that almost all U.S. healthcare companies currently rated as high-default-risk are backed by private equity, positioning 2024 for another wave of PE-linked bankruptcies. This forecast assumes stable or rising interest rates and suggests that portfolio company refinancing and debt maturity events will continue testing the viability of highly leveraged PE healthcare acquisitions. For institutional investors and fund managers tracking healthcare sector dynamics, the correlation between PE ownership and bankruptcy risk represents a material consideration in valuations, debt securities, and systemic risk assessments across healthcare provider and services segments.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.